LB

Lionel Breton

LS L'Oreal S.A.: 66 patents #2 of 559Top 1%
L' L'Oreal: 39 patents #30 of 2,221Top 2%
Google: 4 patents #6,390 of 22,993Top 30%
SS Societe Des Produits Nestle S.A.: 1 patents #653 of 1,324Top 50%
Overall (All Time): #12,438 of 4,157,543Top 1%
108
Patents All Time

Issued Patents All Time

Showing 76–100 of 108 patents

Patent #TitleCo-InventorsDate
6054137 Promoting epidermal renewal with phloroglucinol Florence Girerd, Beatrice Renault 2000-04-25
6048855 Topical composition containing capsazepine Olivier De Lacharriere 2000-04-11
6019967 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin Olivier De Lacharriere 2000-02-01
5993833 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition Olivier De Lacharriere, Catherine Cohen 1999-11-30
5989568 Cosmetic/dermatological skin care compositions comprising S-DHEA Olivier De Lacharriere 1999-11-23
5985293 Antioxidative dermocosmetic compositions comprising very low dosages of melatonin/analogs Pierre Tachon, Francis Pruche, Catherine Gerst, Jean-Francois Nadaud 1999-11-16
5976559 Compositions and methods for treating wrinkles and/or fine lines of the skin Olivier De Lacharriere 1999-11-02
5972892 Topical composition containing a substance P antagonist Olivier De Lacharriere 1999-10-26
5968532 Use of an ethylenediamine derivative in a cosmetic or dermatological composition containing in particular a product having an irritant side effect Oliver De Lacharriere, Jean-Baptiste Galey, Jacqueline Dumats 1999-10-19
5958432 Cosmetic/pharmaceutical compositions comprising .beta.-adrenergic agonists/substance P antagonists Olivier De Lacharriere, Jacques Leclaire 1999-09-28
5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin Olivier De Lacharriere 1999-08-10
5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema Olivier De Lacharriere 1999-08-03
5902805 Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same Olivier De Lacharriere 1999-05-11
5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists Olivier De Lacharriere 1999-05-04
5900242 Cosmetic/dermatological skin care compositions comprising S-DHEA Olivier De Lacharriere 1999-05-04
5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists Olivier De Lacharriere 1999-04-20
5869068 Compositions and methods for treating wrinkles and/or fine lines of the skin Olivier De Lacharriere 1999-02-09
5866168 Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists Olivier De Lacharriere 1999-02-02
5858024 Composition for dyeing keratin fibres containing a substance P antagonist Olivier De Lacharriere, Geneviève Loussouarn 1999-01-12
5851556 Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained Olivier De Lacharriere 1998-12-22
5849312 Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin Olivier De Lacharriere 1998-12-15
5846552 Use of 2,4-diaminopyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders Yann Mahe, Jean-Baptiste Galey, Bruno Bernard 1998-12-08
5824650 Topical composition containing a substance P antagoinst Olivier De Lacharriere 1998-10-20
5803095 Permanent wave compositions comprising substance P/CGRP antagonists Olivier De Lacharriere, Geneviève Loussouarn 1998-09-08
5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it Lucien Aubert, Jacques Leclaire, Richard Martin, Olivier De Lacharriere 1998-08-18